Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug;3(4):495-500.

Fifty years chlorpromazine: a historical perspective

Thomas A Ban  1
Affiliations

Fifty years chlorpromazine: a historical perspective

Thomas A Ban. Neuropsychiatr Dis Treat. 2007 Aug.

Abstract

Chlorpromazine was synthesized in December 1951 in the laboratories of Rhône-Poiulenc, and became available on prescription in France in November 1952. Its effectiveness was reflected in the transformation of disturbed wards; its commercial success stimulated the development of other psychotropic drugs. Recognition of chemical mediation at the site of the synapse, followed by the introduction of the spectrophotofluorimeter first, and receptor assays subsequently, led to the demonstration that chlorpromazine blocks dopamine receptors. Treatment with chlorpromazine focused attention on the heterogeneity of schizophrenia in terms of responsiveness to treatment. By the mid-1980s there was sufficient evidence to believe that resolving this heterogeneity is a prerequisite for developing more effective treatments. Chlorpromazine was instrumental in the development of neuropsychopharmacology, a new discipline dedicated to the study of mental pathology with the employment of centrally acting drugs.

Keywords: chlorpromazine; history; neuropsychopharmacology; pharmacotherapy; psychiatry; schizophrenia.

PubMed Disclaimer

References

    1. Anton-Stephens D. Preliminary observations on the psychiatric uses of chlorpromazine (Largactil) Journal of Mental Science. 1954;100:543–57. - PubMed
    1. Arnold OH, Hilt S, Solma W. Über die Anwendung eines vegatativen Hemmungs stoffes in der psychiatrischen Therapie. Wiener Medizinische Wochenschrift. 1952;102:965–9. - PubMed
    1. Ayd FJ. A clinical analysis of the differential effects of phenothiazine derivatives. In: Bradley PB, Deniker P, Radouco-Thomas C, editors. Neuropsychopharmacology . Amsterdam: Elsevier; 1959. pp. 487–8.
    1. Ban TA. Psychopharmacology. Baltimore: Williams & Wilkins; 1969. p. 431.
    1. Ban TA. Schizophrenia: A Psychopharmacological Approach. Springfield: Charles C. Thomas; 1972. pp. 68–70.

LinkOut - more resources